Ligand Pharmaceuticals Incorporated (LGND) — Strategic Asset Allocation Index
Ligand Pharmaceuticals Incorporated (LGND) has a Strategic Asset Allocation Index of 35.9% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $364.83 Million) total $364.83 Million, measured against net assets of $1.02 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Ligand Pharmaceuticals Incorporated Strategic Asset Allocation Index (2002–2025)
This chart shows how Ligand Pharmaceuticals Incorporated's Strategic Asset Allocation Index has evolved across 20 annual periods from 2002 to 2025. As of December 2025, the index stands at 35.9%, representing strategic assets of $364.83 Million against net assets of $1.02 Billion USD. Explore how efficiently does Ligand Pharmaceuticals Incorporated generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Ligand Pharmaceuticals Incorporated (2002–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Ligand Pharmaceuticals Incorporated from 2002 to 2025, covering 20 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Ligand Pharmaceuticals Incorporated stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 35.9% | $364.83 Million | $- | $364.83 Million | $1.02 Billion | ▲ +12.3 pp |
| 2024 | 23.6% | $195.93 Million | $- | $195.93 Million | $830.44 Million | ▲ +16.7 pp |
| 2023 | 6.9% | $48.32 Million | $- | $48.32 Million | $700.91 Million | ▲ +1.8 pp |
| 2022 | 5.1% | $30.49 Million | $27.49 Million | $3.00 Million | $597.49 Million | ▲ +1.1 pp |
| 2021 | 4.0% | $32.75 Million | $32.75 Million | $- | $821.16 Million | ▲ +2.0 pp |
| 2020 | 2.0% | $14.43 Million | $14.43 Million | $- | $709.52 Million | ▲ +1.1 pp |
| 2019 | 0.9% | $7.18 Million | $7.18 Million | $- | $767.23 Million | ▼ 0.0 pp |
| 2018 | 1.0% | $5.37 Million | $5.37 Million | $0.00 | $560.91 Million | ▼ -1.6 pp |
| 2017 | 2.5% | $10.65 Million | $4.21 Million | $6.44 Million | $418.65 Million | ▼ -0.2 pp |
| 2016 | 2.7% | $10.16 Million | $1.82 Million | $8.35 Million | $370.85 Million | ▼ -7.1 pp |
| 2015 | 9.9% | $30.10 Million | $372.00K | $29.73 Million | $304.39 Million | ▼ -24.1 pp |
| 2014 | 33.9% | $8.28 Million | $867.00K | $7.42 Million | $24.41 Million | ▲ +32.2 pp |
| 2013 | 1.7% | $867.00K | $867.00K | $- | $49.61 Million | ▼ -32.2 pp |
| 2012 | 34.0% | $8.99 Million | $788.00K | $8.21 Million | $26.48 Million | ▲ +28.7 pp |
| 2011 | 5.3% | $455.00K | $455.00K | $- | $8.65 Million | ▼ -222.4 pp |
| 2009 | 227.6% | $8.52 Million | $8.52 Million | $- | $3.74 Million | ▲ +217.8 pp |
| 2007 | 9.8% | $2.87 Million | $2.87 Million | $- | $29.11 Million | ▼ -10.5 pp |
| 2006 | 20.3% | $5.55 Million | $5.55 Million | $- | $27.35 Million | ▼ -12.9 pp |
| 2003 | 33.2% | $23.50 Million | $23.50 Million | $- | $70.73 Million | ▲ +20.2 pp |
| 2002 | 13.1% | $9.67 Million | $9.67 Million | $- | $74.02 Million | — |